A member of Congress said during the conference that he was sympathetic to industry efforts to change the time before drugs and biologics are subject to price negotiations. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
